Verax Biomedical Incorporated Revenue and Competitors

Boston, MA USA

Location

$64.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Verax Biomedical Incorporated's estimated annual revenue is currently $2.1M per year.(i)
  • Verax Biomedical Incorporated's estimated revenue per employee is $77,500
  • Verax Biomedical Incorporated's total funding is $64.8M.

Employee Data

  • Verax Biomedical Incorporated has 27 Employees.(i)
  • Verax Biomedical Incorporated grew their employee count by -13% last year.

Verax Biomedical Incorporated's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
Chief Marketing & Business Development OfficerReveal Email/Phone
3
CEOReveal Email/Phone
4
Sr. VP OperationsReveal Email/Phone
5
VP, Research and DevelopmentReveal Email/Phone
6
SVP, Research & DevelopmentReveal Email/Phone
7
VP SalesReveal Email/Phone
8
VP, Technical Support & TrainingReveal Email/Phone
9
Director, Assay DevelopmentReveal Email/Phone
10
SVP and Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Verax Biomedical Incorporated?

Verax Biomedical is a privately held medical products company, founded in 1999 with the vision of developing proprietary bacterial testing techniques intended to address key unmet medical and safety needs. The Company’s laboratory facilities are in Worcester, Massachusetts, just west of Boston. This location provides an ideal setting for biomedical development. Massachusetts offers an unsurpassed infrastructure, supportive biomedical community and access to a skilled workforce as well as centers of clinical and academic excellence.

keywords:N/A

$64.8M

Total Funding

27

Number of Employees

$2.1M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Verax Biomedical Incorporated News

2022-04-20 - Chippendales lobbies up- POLITICO

Akin Gump Strauss Hauer & Feld: Verax Biomedical Inc. ... Carmen Group Incorporated: Koch Companies Public Sector, LLC

2022-04-17 - Byrne registers to lobby- POLITICO

Congaree River Group LLC: Wejo Data Services, Incorporated ... Akin Gump Strauss Hauer & Feld: Verax Biomedical Inc.

2013-10-09 - Verax Biomedical Closes $12MM Funding Round

Funding supports ongoing commercialization of Platelet PGD® Test; positions company for significant expansion and market growth in 2014 MARLBOROUGH, Mass.–(BUSINESS WIRE)–October 9, 2013– Signaling its intent to capitalize on the opportunity for its Platelet PGD® test for the detection of bact ...

2013-10-09 - Technology to screen blood for bacteria before transfusions raises $12M

Among Verax Biomedical’s investors are Village Ventures and KB Partners. The company points points out that the risk of bacterial contamination in red blood cells is lower than in platelets but it is far higher than the risk of contracting associated with transmitting viruses such as HIV, Hepat ...

2012-10-26 - Diagnostics firm with bacteria detection for blood transfusions raising $5 million

Solution/product: Its Pan Genera Detection technology is aimed at detecting bacterial contamination in cells and tissues for blood transfusions and transplantations. Its Platelet PGD Test is the only test approved by the US Food and Drug Administration to detect bacterial contamination in platel ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.2M288%N/A
#2
$2.8M28-18%N/A
#3
$2.8M284%N/A
#4
$4.8M288%N/A
#5
$6.6M29-9%N/A